Cardiol Therapeutics (CRDL) Shares Outstanding (Weighted Average): 2021-2022
Historic Shares Outstanding (Weighted Average) for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $61.9 million.
- Cardiol Therapeutics' Shares Outstanding (Weighted Average) rose 44.23% to $61.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $61.9 million, marking a year-over-year increase of 44.23%. This contributed to the annual value of $44.0 million for FY2021, which is N/A change from last year.
- According to the latest figures from Q3 2022, Cardiol Therapeutics' Shares Outstanding (Weighted Average) is $61.9 million, which was up 0.02% from $61.9 million recorded in Q2 2022.
- In the past 5 years, Cardiol Therapeutics' Shares Outstanding (Weighted Average) registered a high of $61.9 million during Q3 2022, and its lowest value of $42.9 million during Q2 2021.
- For the 2-year period, Cardiol Therapeutics' Shares Outstanding (Weighted Average) averaged around $52.6 million, with its median value being $53.0 million (2021).
- Data for Cardiol Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 44.23% (in 2022) over the last 5 years.
- Cardiol Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $44.0 million in 2021, then surged by 44.23% to $61.9 million in 2022.
- Its last three reported values are $61.9 million in Q3 2022, $61.9 million for Q2 2022, and $61.9 million during Q1 2022.